Multifunctioning pH-responsive nanoparticles from hierarchical self-assembly of polymer brush for cancer drug delivery

Polymer nanoparticles are extensively explored as drug carriers but they generally have issues of premature burst drug release, slow cellular uptake, and retention in acidic intracellular compartments. Herein, we report multifunctioning three-layered nanoparticles (3LNPs) that can overcome these pro...

Full description

Saved in:
Bibliographic Details
Published in:AIChE journal Vol. 54; no. 11; pp. 2979 - 2989
Main Authors: Shen, Youqing, Zhan, Yihong, Tang, Jianbin, Xu, Peisheng, Johnson, Patrick A, Radosz, Maciej, Van Kirk, Edward A, Murdoch, William J
Format: Journal Article
Language:English
Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01-11-2008
Wiley Subscription Services
American Institute of Chemical Engineers
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Polymer nanoparticles are extensively explored as drug carriers but they generally have issues of premature burst drug release, slow cellular uptake, and retention in acidic intracellular compartments. Herein, we report multifunctioning three-layered nanoparticles (3LNPs) that can overcome these problems. The 3LNPs have a poly(ε-caprolactone) (PCL) core, a pH-responsive poly[2-(N,N-diethylamino)ethyl methacrylate](PDEA) middle layer and a polyethylene glycol (PEG) outer layer. The pH-responsive PDEA layer is insoluble at pH above 7 but becomes positively charged and soluble via protonation at pH lower than 6.5. Thus, this layer has three functions: it covers on the PCL core inhibiting the premature burst drug release at the physiological pH, becomes positively charged and thus promotes endocytosis for fast cellular internalization in the acidic interstitium of solid tumors, and is highly positively charged in lysosomes to disrupt the lysosomal membrane and release the nanoparticle into the cytosol. The multifunctioning nanoparticles are an efficient carrier for cancer cytosolic drug delivery. © 2008 American Institute of Chemical Engineers AIChE J, 2008
Bibliography:http://dx.doi.org/10.1002/aic.11600
ArticleID:AIC11600
National Science Foundation - No. DMR-0705298
istex:765C6ECE0745328E0390421DA13617A7D4497B9D
ark:/67375/WNG-0SK0MNDH-B
American Cancer Society - No. RSG-06-118-01-CDD
National Institutes of Health - No. RR-016474
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0001-1541
1547-5905
DOI:10.1002/aic.11600